|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
and Its Adaptor Protein p62 in Voltage-Gated Potassium Channel Modulation in Pulmonary ArteriesDepartment of Pharmacology, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain
Voltage-gated potassium (KV) channels play an essential role in regulating pulmonary artery function, and they underpin the phenomenon of hypoxic pulmonary vasoconstriction. Pulmonary hypertension is characterized by inappropriate vasoconstriction, vascular remodeling, and dysfunctional KV channels. In the current study, we aimed to elucidate the role of PKC
and its adaptor protein p62 in the modulation of KV channels. We report that the thromboxane A2 analog 9,11-dideoxy-11
,9
-epoxymethano-prostaglandin F2
methyl acetate (U46619
[GenBank]
) inhibited KV currents in isolated mice pulmonary artery myocytes and the KV current carried by human cloned KV1.5 channels expressed in Ltk– cells. Using protein kinase C (PKC)
–/– and p62–/– mice, we demonstrate that these two proteins are involved in the KV channel inhibition. PKC
coimmunoprecipitated with KV1.5, and this interaction was markedly reduced in p62–/– mice. Pulmonary arteries from PKC
–/– mice also showed a diminished [Ca2+]i and contractile response, whereas genetic inactivation of p62–/– resulted in an absent [Ca2+]i response, but it preserved contractile response to U46619.
[GenBank]
These data demonstrate that PKC
and its adaptor protein p62 play a key role in the modulation of KV channel function in pulmonary arteries. These observations identify PKC
and/or p62 as potential therapeutic targets for the treatment of pulmonary hypertension.
Address correspondence to: Dr. Francisco Perez-Vizcaino, Department of Pharmacology, School of Medicine, Universidad Complutense, 28040 Madrid, Spain. E-mail: fperez{at}med.ucm.es
This article has been cited by other articles:
![]() |
A. Cogolludo, L. Moreno, G. Frazziano, J. Moral-Sanz, C. Menendez, J. Castaneda, C. Gonzalez, E. Villamor, and F. Perez-Vizcaino Activation of neutral sphingomyelinase is involved in acute hypoxic pulmonary vasoconstriction Cardiovasc Res, May 1, 2009; 82(2): 296 - 302. [Abstract] [Full Text] [PDF] |
||||